{
    "id": "dbpedia_4803_2",
    "rank": 68,
    "data": {
        "url": "https://cajal.csic.es/en/neurovascular-research-group/",
        "read_more_link": "",
        "language": "en",
        "title": "Ricardo Martínez Murillo´s Group",
        "top_image": "https://cajal.csic.es/wp-content/uploads/2023/01/cropped-favicon-32x32.png",
        "meta_img": "https://cajal.csic.es/wp-content/uploads/2023/01/cropped-favicon-32x32.png",
        "images": [
            "http://cajal.csic.es/wp-content/uploads/2023/03/logo-cajal-web-2023_lowQ.jpg",
            "http://cajal.csic.es/wp-content/uploads/2023/01/grupo-neurovascular-ricardo.jpg",
            "http://cajal.csic.es/wp-content/uploads/2023/01/imagen-rmn-ricard.jpg",
            "http://cajal.csic.es/wp-content/uploads/2023/01/imagen-alzheimer-ricardo.jpg",
            "http://cajal.csic.es/wp-content/uploads/2023/01/neurogliosis01-ricardo.jpg",
            "http://cajal.csic.es/wp-content/uploads/2023/01/neurogliosis02-ricardo.jpg",
            "http://cajal.csic.es/wp-content/uploads/2023/01/neurogliosis03-ricardo.jpg",
            "http://cajal.csic.es/wp-content/uploads/2023/01/estudio-de-rmn-ricardo.jpg",
            "http://cajal.csic.es/wp-content/uploads/2023/01/ricardo-martinez-murillo.jpg",
            "http://cajal.csic.es/wp-content/uploads/2023/01/adolfo-toledano.jpg",
            "http://cajal.csic.es/wp-content/uploads/2023/01/julia-serrano.jpg",
            "http://cajal.csic.es/wp-content/uploads/2023/01/patricia-fernandez.jpg",
            "http://cajal.csic.es/wp-content/uploads/2023/01/aitana-sanchez.jpg",
            "http://cajal.csic.es/wp-content/uploads/2023/01/csic-logo.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2023-03-25T13:00:31+00:00",
        "summary": "",
        "meta_description": "Information about the Ricardo Martínez Murillo´s Group, a neuroscience research laboratory of the Cajal Institute (CSIC)",
        "meta_lang": "en",
        "meta_favicon": "https://cajal.csic.es/wp-content/uploads/2023/01/cropped-favicon-32x32.png",
        "meta_site_name": "Instituto Cajal - CSIC",
        "canonical_link": "https://cajal.csic.es/en/neurovascular-research-group/",
        "text": "LABORATORIOS\n\nNeurovascular research group\n\nNeurovascular research group\n\nResearch\n\nTeam\n\nPublications\n\nContact\n\nOthers\n\nResearch\n\nThe lines of work and research of the group focus on the study of the Neurovascular Unit in physiological (including physiological senile aging) and pathological situations, as well as the evaluation of strategies for its protection and repair.\n\nDysfunction of the Neurovascular Unit predisposes or aggravates the development of diseases with a high socioeconomic impact, such as acute cerebrovascular accident (stroke), chronic neurodegenerative diseases, particularly Alzheimer’s disease (AD), and tumor progression.\n\nIn this sense, we investigate the protection and repair mechanisms of the Neurovascular Unit, looking for appropriate molecules for the treatment of these diseases of great clinical and epidemiological importance, both due to their prevalence, incidence and mortality, as well as the degree of sequelae they generate..\n\nTo address our objectives we use experimental models in rodents and anatomical and imaging techniques (Nuclear Magnetic Resonance, NMR) as well as histochemical, biochemical, cell and molecular biology techniques and behavioral assays.\n\nDo you want to collaborate with us?\n\nIf you are interested in our lines of research and want to propose a project, a contract or want to develop your research training in our group, contact us.\n\n+34 915 854 714\n\nr.martinez@cajal.csic.es\n\nLines of investigation\n\n1) Cerebral ischemia\n\nWe tested: new molecules for the treatment of ischemic stroke.\n\nWe used: a mouse model of ligation of the middle cerebral artery.\n\nWe value:\n\nMRI infarct volumes\n\nMarkers that are altered in ischemic stroke using Histochemistry, Immunohistochemistry, Biochemistry and Molecular Biology techniques.\n\nImprovement through animal behavior tests.\n\nThese images are from an NMR study. The use of this technique allows us to assess the volume of the cerebral infarction produced by ligating the middle cerebral artery, an experimental stroke model that we use in the evaluation of new molecules for its treatment, as we can see in the image on the right.\n\n2) Alzheimer´s disease\n\nWe tested: New molecules to slow or stop Alzheimer’s disease.\n\nWe employ:\n\nA mouse model of the disease, double transgenic for human amyloid precursor protein (APP swe) and presenilin 1 (PSEN1 dE9).\n\nSections from Alzheimer’s patients.\n\nWe value:\n\nVariation in β-amyloid (Aβ) load.\n\nGliosis, inflammation and neurodegeneration using Histochemistry, Immunohistochemistry, Biochemistry and Molecular Biology techniques.\n\nImprovement through animal behavior tests.\n\nImage taken with a fluorescence microscope. The section is stained with Thioflavin-S to quantify β-amyloid deposits in a model of Alzheimer’s disease, and to assess the effect of new molecules for its treatment.\n\nThese microphotographs show different patterns of neurogliosis and its relationship with beta amyloid plaques in sections from Alzheimer’s disease.\n\n3) Brain tumors\n\nWe tested: the use of nanoparticles (Nanohyperthermia) to stop tumor progression.\n\nWe used: a murine orthotopic model produced by intracerebral injection of tumor cells\n\nWe value:\n\nTumor volumes by MRI.\n\nTumor markers using Histochemistry, Immunohistochemistry, Biochemistry and Molecular Biology techniques.\n\nThese images are from an NMR study. The use of this technique allows us to assess the volume of a brain tumor produced by transplanting glioblastoma tumor cells into a mouse (host), thus obtaining an appropriate experimental model of glioblastoma intracerebral tumor progression that we use in evaluating new therapies.\n\nTeam\n\nRicardo Martínez\n\nPrincipal Investigator\n\nAdolfo Toledano\n\nAd Honorem Proffessor\n\nJulia Serrano\n\nPostoctoral Researcher\n\nPatricia Fernández\n\nPostoctoral Researcher\n\nAitana Sánchez\n\nStudent\n\nPublications\n\nEmelina R. Rodríguez-Ruiz, Raquel Herrero-Labrador, Ana P. Fernández-Fernández, Julia Serrano-Masa,José A. Martínez-Montero, Daniel González-Nieto, Mayuri Hana-Vaish, Mohamed Benchekroun ,Lhassane Ismaili*, José Marco-Contelles and Ricardo Martínez-Murillo*, The Proof-of-Concept of MBA121, a Tacrine–Ferulic AcidHybrid, for Alzheimer’s Disease Therapy. Internat. J. of Molecular Sciences, 24, 12254, 2023. https://doi.org/10.3390/ijms241512254\n\nKnez, Damijan; Diez-Iriepa, Daniel); Chioua, Mourad; Gottinger, Andrea); Denic, Milica ; Chantegreil, Fabien; Nachon, Florian; Brazzolotto, Xavier); Skrzypczak-Wiercioch, Anna; Meden, Anze; Pislar, Anja; Kos, Janko); Zakelj, Simon; Stojan, Jure; Salat, Kinga; Serrano, Julia; Fernandez, Ana Patricia; Sanchez-Garcia, Aitana; Martinez-Murillo, Ricardo; Binda, Claudia; Lopez-Munoz, Francisco); Gobec, Stanislav); Marco-Contelles, Jose. 8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases. Acata Pharmaceutica Sinca, 13, 2152-2174, 2023. https://doi.org/10.1016/j.apsb.2023.01.013\n\nChamorro, Beatriz; Izquierdo-Bermejo, Sara; Serrano, Julia; Hadjipavlou-Litina, Dimitra; Chioua, Mourad; Lopez-Munoz, Francisco; Marco-Contelles, Jose; Martinez-Murillo, Ricardo; Oset-Gasque, Maria Jesus, Neuroprotective and antioxidant properties of new quinolylnitrones in in vitro and in vivo cerebral ischemia models, Scientific Reports, Volume 13, Issue 1, 2023. DOI: http://dx.doi.org/10.1038/s41598-023-29929-7\n\nGarcia-Pena, Pablo; Ramos, Milagros; Lopez, Juan M.; Martinez-Murillo, Ricardo; de Arcas, Guillermo); Gonzalez-Nieto, Daniel), Preclinical examination of early-onset thalamic-cortical seizures after hemispheric stroke. Epilepsia, 2023. https://doi.org/10.1073/pnas.120529710\n\nFernandez-Serra, R ; Martinez-Alonso, E; Alcazar, A; Chioua, M; Marco-Contelles, J; Martinez-Murillo, R; Ramos, M; Guinea, GV; Gonzalez-Nieto, D, Postischemic Neuroprotection of Aminoethoxydiphenyl Borate Associates Shortening of Peri-Infarct Depolarizations. International Journal of Molecular Sciences, 23, 7449, 2022. https://doi.org/10.3390/ijms23137449\n\nThe use of Silica Microparticles to Improve the Efficiency of Optical Hyperthermia (OH). Casanova-Carvajal, O; Zeinoun, M; Urbano-Bojorge, AL; Bacha, F; Livi, JS; Agudo, E; Vargas, G; Ramos, M; Martinez-Murillo, R; Serrano-Olmedo, JJ. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 (10) (2021)\n\nDOI: 10.3390/ijms22105091\n\nReflections on cerebellar neuropathology in classical scrapie. Toledano-Díaz A, Álvarez MI, Rodríguez JJ, Badiola JJ, Monzón M, Toledano A. BIOMOLECULES Apr 28; 11(5):649 (2021) DOI: 10.3390/biom11050649\n\nSynthesis, antioxidant properties and neuroprotection of alpha-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models. Chamorro, B; Diez-Iriepa, D; Merás-Sáiz, B; Chioua, M; García-Vieira, D; Iriepa, I; Hadjipavlou-Litina, D; López-Muñoz, F; Martínez-Murillo, R; Gonzàlez-Nieto, D; Israel Fernández, I; Marco-Contelles, J; and Oset-Gasque, MJesús. SCIENTIFIC REPORTS 10 (1), 2020. DOI: 10.1038/s41598-020-70690-y\n\nBiomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows. Gonzalez-Nieto, D; Fernandez-Serra, R; Perez-Rigueiro, J; Panetsos, F Martinez-Murillo, R; Guinea, GV. CELLS 9 (5) (2020). DOI: 10.3390/cells9051074\n\nGlial Alterations in Aging and Alzheimer’s disease: A novel basis to understand, prevent and treat the degenerative process. Toledano-Díaz A, Álvarez MI, Toledano A. OBM GERIATRICS 4 (2020). DOI: 10.21926/obm.geriatr.2002117\n\nHippocampal CCR5/RANTES elevations in a rodent model of post-traumatic stress disorder: Maraviroc (a CCR5 Antagonist) increases corticosterone levels and enhances fear memory consolidation. Merino JJ, Muñetón-Gomez V, Muñetón-Gómez C, Pérez-Izquierdo MÁ, Loscertales M, Toledano A.\n\nBIOMOLECULES FEB 1; 10(2):212 (2020). DOI: 10.3390/biom10020212\n\nSynthesis, neuroprotective and antioxidant capacity of PBN-related indanonitrones. Jimenez-Almarza, A; Diez-Iriepa, D; Chioua, M; Chamorro, B; Iriepa, I; Martinez-Murillo, R; Hadjipavlou-Litina, D; Oset-Gasque, MJ and Marco-Contelles, J. May 2019 | BIOORGANIC CHEMISTRY 86, pp.445-451, 2019\n\nDOI: 10.1016/j.bioorg.2019.01.071\n\nSlowdown intracranial glioma progression by optical hyperthermia therapy: study on a CT-2A mouse astrocytoma model. Casanova-Carvajal, O; Urbano-Bojorge, AL; Ramos, M; Serrano-Olmedo, JJ; and Martinez-Murillo, R. NANOTECHNOLOGY 30 (35), 2019. DOI: 10.1088/1361-6528/ab2164\n\nElevated systemic L-Kynurenine/L-Tryptophan ratio andi increased IL-1 beta and Chemokine (CX3CL1, MCP-1) proinflammatory mediators in patients with long-term titanium dental implants. Merino JJ, Cabaña Muñoz ME, Toledano A, Garcimartín A, Benedí, J, Camacho Alonso F, Parmigiani Izquierdo JM.\n\nJ CLIN MED SEP 2; 8(9):1368 (2019). DOI: 10.3390/jcm8091368\n\nThe long-term algae extract and aminosulphurate supplementation modulates SOD-1 activity and decrease heavymetals levels in patients with long-term dental titanium implants and amalgam fillings restorations. Merino JJ, Parmigiani Izquierdo JM, Toledano A,Cabaña Muñoz ME. ANTIOXIDANTS 2019 APR 16, 8(4):101 (2019). DOI: 10.3390/antiox8040101. 8-4\n\nCortical Reshaping and Functional Recovery Induced by Silk Fibroin Hydrogels-Encapsulated Stem Cells Implanted in Stroke Animals. Fernandez-Garcia, L; Perez-Rigueiro, J; Martinez-Murillo, R ; Panetsos, F; Ramos, M; Guinea, GV; Gonzalez-Nieto, D. FRONTIERS IN CELLULAR NEUROSCIENCE 12 (2018)\n\nDOI: 10.3389/fncel.2018.00296\n\nThe APPswe/PS1A246E mutations in an astrocytic cell line leads to increased vulnerability to oxygen and glucose deprivation, Ca2+ dysregulation, and mitochondrial abnormalities. Martin-de-Saavedra, MD; Navarro, E; Moreno-Ortega, AJ; Cunha, MP; Hernansanz-Agustin, P ; Leon, R; Cano-Abad, MF ; Martinez-Ruiz, A; Martinez-Murillo, R; Duchen, MR; Lopez, MG. JOURNAL OF NEUROCHEMISTRY 145 (2), pp.170-182 (2018). DOI: 10.1111/jnc.14293\n\nNeuron-Astrocyte Signaling is preserved in the Aging Brain. Gomez-Gonzalo, M ; Martin-Fernandez, M ; Martinez-Murillo, R ; Mederos, S ; Hernandez-Vivanco, A ; Jamison, S ;Fernandez AP ; Serrano, J ; Calero, P ; Futch, HS ; Corpas, R ; Sanfeliu, C ; Perea, G ; Araque, A. GLIA: 65 (4):569-580 (2017). DOI: 10.1002/glia.23112\n\nThe proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease. Serrano, MP ; Herrero-Labrador, R ; Futch, HS ; Serrano, J ; Romero, A ; Fernandez AP ; Samadi, A ; Unzeta, M ; Marco-Contelles, J ; Martinez-Murillo, R. JOURNAL OF PSYCHIATRY & NEUROSCIENCE: 42(1):59-69 (2017). DOI: 10.1503/jpn.150209\n\nDefective insulin signaling, mediated by inflammation, connects Obesity to Alzheimer Disease; relevant pharmacological therapies and preventive dietary interventions. Rodriguez-Casado A, Toledano-Díaz A, Toledano A. CURR ALZH RES.; 14(8):894-911 (2017). DOI: 10.2174/1567205014666170316161848\n\nIn Vitro evaluation of Biocompatibility of Uncoated Thermally reduced graphene and carbon nanotube-loaded PVDF Membranes with adult neural stem cell-Derived neurons and glia. Defterali, C; Verdejo, R; Majeed, S; Boschetti-de-Fierro, A; Mendez-Gomez, HR ; Diaz-Guerra, E; Fierro, D; Buhr, K; Abetz, C; Martinez-Murillo, R ; Vuluga, D; Alexandre, M; Thomassin, JM; Detrembleur, C; Jerome, C; Abetz, V; Lopez-Manchado, MA; Vicario-Abejon, C. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY 4 (2016). DOI: 10.3389/fbioe.2016.00094\n\nMethylene blue prevents retinal damage in an experimental model of ischemic proliferative retinopathy. Rey-Funes, M; Larrayoz, IM; Fernandez, JC; Contartese, DS; Rolon, F; Inserra, PIF; Martinez-Murillo, R; Lopez-Costa, JJ; Dorfman, VB; Martinez, A; Loidl, CF. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY 310 (11), pp.R1011-R101 (2016). DOI: 10.1152/ajpregu.00266.2015\n\nThermally reduced graphene is a permissive material for neurons and astrocytes and de novo neurogenesis in the adult olfactory bulb in vivo\n\nDefterali, C; Verdejo, R; Peponi, L; Martin, ED; 4Martinez-Murillo, R ; Lopez-Manchado, MA; Vicario-Abejon, C. BIOMATERIALS 82, pp.84-93 (2016). DOI: 10.1016/j.biomaterials.2015.12.010\n\nLong-term dynamics of somatosensory activity in a stroke model of distal middle cerebral artery oclussion. Barrios, JA ; Pisarchyk, L; Fernandez-Garcia, L; Barrio, LC; Ramos, M; Martinez-Murillo, R; Gonzalez-Nieto, D. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 36 (3) , pp.606-620 (2016). DOI: 10.3390/ijms22105091\n\nAdrenomedullin Expression in Alzheimer’s Brain. Fernandez AP; Masa, JS ; Guedan, MA ; Futch, HS ; Martinez-Murillo, R. CURRENT ALZHEIMER RESEARCH: 13 (4): 428-438 (2016). DOI: 10.2174/1567205013666160229112725\n\nASS234, As a New Multi-Target Directed Propargylamine for Alzheimer’s disease Therapy. Marco-Contelles J, Unzeta M, Bolea I, Esteban G, Ramsay RR, Romero A, Martinez-Murillo R, Carreiras MC, Ismaili L. FRONT NEUROSCI: 10:294 (2016). DOI: 10.3389/fnins.2016.00294\n\nLack of adrenomedullin in mouse endothelial cells results in defective angiogenesis, enhanced vascular permeability, less metastasis, and more brain damage. Ochoa-Callejero L, Pozo-Rodrigalvarez A, Martinez-Murillo R, Martinez A. SCI REP; 6:33495 (2016). DOI: 10.1038/srep33495\n\nBrain local and regional neuroglial alterations in Alzheimer’s disease: cell types, responses and implications. Toledano A, Álvarez MI, Toledano-Díaz A, Merino JJ, Rodríguez JJ.. CURR ALZH RES. 13(4):321-342 (2016). DOI: 10.2174/1567205013666151116141217\n\nBlood-based biomarkers of Alzheimer’s disease: diagnostic algorithms and new technologies. Carmona P, Molina M, Toledano A. ICURR ALZH RES.; 13(4):450-464 (2016). DOI: 10.2174/1567205013666151116130301\n\nNeuroglia in Alzheimer’s Disease: From Cohort to Contestant in the Disease Progression and its Therapy. Toledano A, Merino JJ, Rodríguez JJ. CURR ALZH RES.; 13(4):318-20 (2016). http://hdl.handle.net/10261/149792\n\nNew concepts on the functionality of the nervous system: the revolution of the glial cells. ii. Glial responses keys in the pathogenesis and treatment of diseases of snc. Toledano A, Álvarez MI, Toledano-Díaz A, Rodríguez-Arellano JJ. AN REAL ACAD FARM 82, 1:51-67 (2016). ISSN (Online) 1697-4298\n\nhttp://hdl.handle.net/10261/150110\n\nThe sigma 1 Receptor Engages the Redox-Regulated HINT1 Protein to Bring Opioid Analgesia under NMDA Receptor Negative Control. Rodriguez-Munoz, M; Sanchez-Blazquez, P ; Herrero-Labrador, R; Martinez-Murillo, R ; Merlos, M; Vela, JM; Garzon, J. ANTIOXIDANTS & REDOX SIGNALING 22 (10) , pp.799-818 (2015). DOI: 10.1089/ars.2014.5993\n\nVibrational spectroscopic analysis of peripheral blood plasma of patients with Alzheimer’s disease. Carmona P, Molina M, López-Tobar E, Toledano A.\n\nANAL BIOANAL CHEM 407 (25):7747-56 (2015). DOI: 10.1007/s00216-015-8940-7\n\nAstroglial cell subtypes in the cerebella of normal adults, elderly adults, and patients with Alzheimer’s disease: a histological and immunohistochemical comparison. Alvarez MI, Rivas L, Lacruz C, Toledano A.. GLIA 63(2):287-312. (2015). DOI: 10.1002/glia.22751\n\nUltrastructural changes in the progress of natural Scrapie regardless fixation protocol. Casanova-Carvajal, O; Zeinoun, M; Urbano-Bojorge, AL; Bacha, F; Livi, JS; Agudo, E; Vargas, G; Sarasa R, Junquera C, Toledano A, Badiola JJ, Monzón M. HISTOCHEM CELL BIOL144 (1):77-85 (2015). DOI 10.1007/s00418-015-1314-6\n\nNew concepts on the functionality of the nervous system: the revolution of the glial cells. I. The neuro-glial relationships. Toledano A, Álvarez MI, Toledano-Díaz A. AN REAL ACAD FARM VOL. 81, 1:11-18 (2015). ISSN (Online) 1697-4298. http://hdl.handle.net/10261/155110\n\nAbout the vibrational spectroscopy in the diagnosis of Alzheimer’s disease. Carmona P, López-Tobar E, Molina M, Toledano A. AN REAL ACAD FARM. 81, 1:19 –24 (2015). http://hdl.handle.net/10261/128196\n\nMethamphetamine Causes Degeneration of Dopamine Cell Bodies and Terminals of the Nigrostriatal Pathway Evidenced by Silver Staining. Ares-Santos, S; Granado, N; Espadas, I; Martinez-Murillo, R; Moratalla, R. NEUROPSYCHOPHARMACOLOGY 39 (5), pp.1066-1080 (2014). DOI: 10.1038/npp.2013.307\n\nDonepezil plus propargylamine+8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer’s disease. Wang, L ; Esteban, G ; Ojima, M ; Bautista-Aguilera, OM ; Inokuchi, T ; Moraleda, I ; Iriepa, I ; Samadi, A ; Youdim, MBH ; Romero, A ; Soriano, E ; Herrero, R ; Fernandez, APF ; Ricardo-Martinez-Murillo ; Marco-Contelles, J ; Unzeta M. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY: 80: 543-561(2014). DOI: 10.1016/j.ejmech.2014.04.078\n\nAstrocytes require insulin-like growth factor I to protect neurons against oxidative injury. Genis, Laura; Davila, David; Fernandez, Silvia; Pozo-Rodrigalvarez, Andrea; Martinez-Murillo, Ricardo; Torres-Aleman, Ignacio. F1000Research 3, pp.28 (2014). DOI: 10.12688/f1000research.3-28.v2\n\nMorphological approach to assess the involvement of astrocytes in prion propagation. Hernández RS, Sarasa R, Toledano A, Badiola JJ, Monzón M.\n\nCELL TISSUE RES. 2014 OCT; 358(1):57-63. (2014). DOI: 10.1007/s00441-014-1928-3\n\nVariability in the effects of nicotine on different regions of the brain: changes in the concentration of superoxide dismutase isoforms. Toledano A, Álvarez MI, Toledano-Díaz A. Cent Nerv Syst Agents Med Chem.; 14(1):10-22. (2014). DOI: 10.2174/1871524914666140507162907\n\nDoes Alzheimer’s disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications (II). Toledano A, Álvarez MI, López-Rodríguez AB, Toledano-Díaz A, Fernández-Verdecia CI. NEUROLOGIA 29(1):42-55 (2014). DOI: 10.1016/j.nrl.2011.05.004\n\nHypothermia prevents gliosis and angiogenesis development in an experimental model of ischemic proliferative retinopathy. Rey-Funes M, Dorfman VB, Ibarra ME, Pena E, Contartese DS, Goldstein J, Acosta JM, Larrayoz IM, Martinez-Murillo R, Martinez A, Loidl CF. INVEST OPHTHALMOL VIS SCI 23-4-; 54:2836-2846 (2013). DOI: 10.1167/iovs.12-11198\n\nCould neurotransmitters influence neurogenesis and neurorepair after stroke?. Sanchez-Mendoza E, Bellver-Landete V, Merino JJ, Gonzalez MP, Martinez-Murillo R, Oset-Gasque MJ. NEUROPATHOL APPL NEUROBIOL 39:722-735 (2013). DOI: 10.1111/nan.12082\n\nDiscrimination analysis of blood plasma associated with Alzheimer’s disease using vibrational spectroscopy. Carmona P, Molina M, Calero M, Bermejo-Pareja F, Martínez-Martín P, Toledano A. J ALZHEIMERS DIS.; 34(4):911-920 (2013). DOI: 10.3233/JAD-122041\n\nOthers\n\nrojects\n\nBRI2 role in neuronal differentiation and the underlying molecular mechanisms: towards an innovative regenerative therapy for Alzheimer’s Disease\n\nFunding entity: Portugal FCT – Fundaço para a Ciência e a Tecnologia (Portuguese national funding agency for science, research and technology)\n\nReference No.: PTDC/BTM-TEC/3792/2021\n\nDuration: 2022-2024\n\nIP: Sandra Maria Tavares da Costa Rebelo and Filipa de Sá Martins\n\nContilisant optimization: design, synthesis and biological evaluation\n\nFunding entity: Ministry of Science, Innovation and Universities\n\nReference No.: PID2019-105813RB-C21\n\nDuration: 2021-2023\n\nIP: José Luis Marco Contelles and Ricardo Martínez Murillo\n\nMolecules for the treatment of complex diseases associated with age\n\nFunding entity: Ministry of Economy and Competitiveness\n\nReference No.: SAF2015-65586-R\n\nDuration: 2016-2019\n\nIP: José Luis Marco Contelles and Ricardo Martínez Murillo\n\nNeurocentro-CM Technological Center for the Study and Integrated Treatment of Neurological Disorders\n\nFinancing entity: Community of Madrid\n\nReference No.: S2017/BMD-3760\n\nDuration: 2018-2022\n\nIP: Ricardo Martínez Murillo (Coordinator: Gustavo Víctor Guinea Tortuero)\n\nDevelopment of new nanoparticles and protocols for enhanced hyperthermia\n\nFunding entity: FIS (CIBER-BBN; INTRAMURAL PROGRAM PROJECT)\n\nReference No.: CIBER-BBN; INTRAMURAL PROGRAM PROJECT\n\nDuration: 2014-2015\n\nIP: Francisco del Pozo Guerrero (Project coordinator: José Javier Serrano Olmedo)\n\nFunctional relevance of the novel complex, APP/Fe65/PP1, for Alzheimer’s disease\n\nFunding entity: State Agency, Higher Council for Scientific Research, Ministry of Science and Innovation\n\nReference No.: PRI-AIBPT-2011-1188\n\nDuration: January 2012 – September 2014 IP: Ricardo Martinez Murillo\n\nAdrenomedullin Peptide in Attention Deficit Hyperactivity Disorder\n\nFunding entity: Alicia Koplowitz Foundation\n\nDuration: October 2010 – October 2012\n\nIP: Ana Patricia Fernandez Fernandez\n\nMechanisms of protection and repair of the neurovascular unit in Alzheimer’s disease\n\nFunding entity: Ministry of Science and Innovation\n\nReference No.: SAF2010-15173\n\nDuration: January 2011 – September 2014\n\nIP: Ricardo Martinez Murillo\n\nStudy of neuroprotective mechanisms in cerebrovascular pathologies\n\nFinancing entity: Ministry of Education and Science\n\nReference No.: SAF2007-60010\n\nDuration: December 2007- December 2010\n\nIP: Ricardo Martinez Murillo\n\nParticipation in the Neurovascular Network (RENEVAS)\n\nFunding entity: Carlos III Health Institute (General Sub-directorate of Networks and Cooperative Research Centers). Ministry of Education and Science\n\nReference No.: RD06/0026/1001\n\nDuration: January 2008 – December 2010\n\nIP: Ricardo Martinez Murillo\n\nDoctoral Thesis\n\nEffect of the Nitric Oxide regulators LA-419 and ONO-1714 in a mouse model of focal cerebral infarction. Andrea Pozo Rodrigálvarez (2014). Autonomous University of Madrid. School of Medicine. Grade: Outstanding Cum Laude\n\nTeaching\n\nMaster in Neuroscience from the Autonomous University of Madrid (UAM-Cajal Institute, CSIC)\n\nSubject: Characterization of Neurotransmitters and Neuroactive\n\nSubstances in the Central Nervous System Immunocytochemistry and Biochemistry (6 ECTS)\n\nFrom 1996 to the present\n\nCourse “Animal and human cells: applications in regenerative medicine”\n\nTaught by the Complutense University of Madrid\n\nFrom 2013 to the present\n\nDirection of Final Degree Projects (TFG) and Final Master’s Projects (TFM)\n\nComplutense University of Madrid, Autonomous University of Madrid,\n\nUniversity of Alcalá de Henares and University of Florida, College of Medicine\n\nAdvanced course on Alzheimer’s disease for health personnel\n\nA Toledano, MI Álvarez, S Toledano-Díaz\n\nApproach to the diagnosis of Alzheimer’s disease\n\nA Toledano, MI Álvarez, S Toledano-Díaz\n\nApproach to the treatment of Alzheimer’s disease\n\nA Toledano, MI Álvarez, S Toledano-Díaz\n\nMental stimulation of Alzheimer’s patients: Occupational Therapy exercises\n\nJ Fernández González, A Toledano, MI Álvarez, S Toledano-Díaz\n\nMonographs / Books\n\nASS234: A New and Promising Anti-Alzheimer Agent\n\nAlejandro Romero, Eva Ramos, Ana P. Fernández, Julia Serrano, Ricardo Martínez-Murillo and José Marco-Contelles\n\nEn: Frontiers in Clinical Drug Research – Alzheimer Disorders, Vol. 7, 12-25 Chapter 2 (2018)\n\nISSN (Online): 2214-5168 ISSN (Print): 2451-8743\n\nAlzheimer pathology in non-human primates and its pathophysiological implications\n\nToledano, A.; Álvarez, M.I.; Carmona, P.; Toledano-Díaz, A.; Fernández-Verdecia, C.I.\n\nEn: Primates. Classification, evolution and behavior. E F Hughes and M Hill (Eds). Nova Sciences Pub. New York, pp 71-110 (2012)\n\nISBN: 978-1620814987\n\nAnimal Models of Brain Tumors\n\nMartínez A., Martinez-Murillo R. (Eds) (2011)\n\nSpringer Science, USA\n\nISBN 978-1-62703-209-4\n\nMultiple neuronal and glial mechanisms can be involved in the response to the activation of nicotinic receptors\n\nToledano A; Alvarez MI; Toledano-Díaz A.\n\nEn: Horizons in Neuroscience Research. Volume 3 Neural Transmissions: Characteristics, Mechanisms and Malfunctioning. A Costa, E Villalba (Eds) Nova Science Publishers, Inc. Hauppauge, NY pp 1-34 (2011)\n\nISBN: 978-1-61728-027-6\n\nLesion-induced vertebrate models of Alzheimer Dementia\n\nA Toledano; Álvarez MI.\n\nEn: Animal models of Dementia. PP Deyn, D Van Dam (Eds). Humana Press, 295-345 (2010)\n\nISBN: 978-1-60761-897-3\n\nCollaborations\n\nGustavo Guinea Tortuero, Centro de Tecnología Biomédica (CTB). Universidad Politécnica de Madrid\n\nJosé Javier Serrano Olmedo, Departamento Tecnología Fotónica y Bioingeniería. Centro de Tecnología Biomédica (CTB). Universidad Politécnica de Madrid\n\nDaniel González Nieto, Centro de Tecnología Biomédica (CTB). Universidad Politécnica de Madrid\n\nJosé Luis Marco Contelles, Laboratorio de Radicales Libres y Química Computacional. Instituto de Química Orgánica General (CSIC)\n\nJuan Manuel García Segura, CAI de Resonancia Magnética Nuclear. Universidad Complutense de Madrid\n\nMaría del Pilar Herrero Martín, Centro de Tecnología Biomédica (CTB). Universidad Politécnica de Madrid\n\nJuan Antonio Barcia Albacar, Hospital Universitario Clínico San Carlos\n\nFivos Panetsos, Facultad de Óptica y Optometría. Universidad Complutense de Madrid\n\nJulio Ángel Mayol Martínez, Hospital Universitario Clínico San Carlos\n\nFernando Maestú Unturbe, Facultad de Psicología. Universidad Complutense de Madrid\n\nFélix Armadá Maresca, Instituto de Investigación Sanitaria. Hospital Universitario La Paz (IDIPAZ)\n\nSandra Maria Tavares da Costa Rebelo, Universidade de Aveiro\n\nFilipa de Sá Martins, Universidade de Aveiro\n\nManuela García López, Instituto Teófilo Hernández. Madrid.\n\nJavier Pérez Castells, Departamento de Química Orgánica. Universidad San Pablo-CEU. Madrid\n\nAlfredo Martínez, Centro de Investigación Biomédica de la Rioja (CIBIR)\n\nCésar Fabián Loidl, Facultad de Medicina. Universidad de Buenos Aires\n\nManuel Rey Funes, Facultad de Medicina. Universidad de Buenos Aires\n\nCarlos Vicario, Departamento de Neurobiología Celular, Molecular y del Desarrollo. Instituto Cajal (CSIC)\n\nGertrudis Perea, Departamento de Neurobiología Funcional y de Sistemas. Instituto Cajal (CSIC)\n\nAlfonso Araque, University of Minnesota\n\nRosario Moratalla, Departamento de Neurobiología Funcional y de Sistemas. Instituto Cajal (CSIC)\n\nIgnacio Torres, Departamento de Neurobiología Funcional y de Sistemas. Instituto Cajal (CSIC)\n\nJavier Garzón, Departamento de Neurociencia Traslacional. Instituto Cajal (CSIC)\n\nPilar Sánchez, Departamento de Neurociencia Traslacional. Instituto Cajal (CSIC)\n\nIgnacio Lizasoain, Departamento de Farmacología y Toxicología. Facultad de Medicina. Universidad Complutense de Madrid\n\nMaría Ángeles Moro, Departamento de Farmacología y Toxicología. Facultad de Medicina. Universidad Complutense de Madrid\n\nJosé Julio Rodríguez Arellano, Grupo de Neuroanatomía Funcional (BioCruces- IKERBASQUE)\n\nMarta Monzón, Centro de Encefalopatías Espongiformes y Enfermedades Emergentes. Universidad de Zaragoza\n\nJuan José Badiola, Centro de Encefalopatías Espongiformes y Enfermedades Emergentes. Universidad de Zaragoza\n\nJosé Joaquín Merino Martín, Facultad de Farmacia. Universidad Complutense de Madrid\n\nAdolfo Toledano Díaz, Departamento de Reproducción Animal (INIA-CSIC)\n\nPedro Carmona, Instituto de Estructura de la Materia (CSIC)\n\nScience dissemination\n\nA Toledano, M I Álvarez, S Toledano-Díaz (2008)\n\nThe complex evolution of Alzheimer’s disease during its hundred years of existence: research, clinical and social health care. Acta Cient Tecnol. 13:31-37\n\nA Toledano, MI Álvarez, A Toledano-Díaz. (2007)\n\nOn the centenary of the Nobel Prize for Cajal: the merit and validity of a transcendental scientific work. Acta Cient Tecnol. 12:24-31\n\nA Toledano. (2007)\n\nCajal: a Nobel, a scientific work and a revolution in the history of medicine. ACTA 43:9-15\n\nToledano A. (2006)\n\nMysterious and dangerous prion diseases or transmissible spongiform encephalopathies: new and revolutionary concepts in pathology. ACTA 41:23-33\n\nToledano A., Alvarez M.I., Toledano S. (2004)\n\nThe REDAFIAL Project of the Alzheimer Foundation Spain and its website http://alzheimer.rediris.es. EnAspectos Socio- sanitarios del Alzheimer. Selmes J., Zaragozá F., Toledano A., Álvarez M.I., Toledano S. (Coordinadores) R. Acad. Farm./Fundación Casares Gil\n\nToledano A. (2003)\n\nAlzheimer’s disease. The difficult balance between the specific and the generic, the possible and the impossible. Acta Científica y Tecnológica. 7:33-40\n\nContracts with companies\n\nStudy of the benefit of the administration of the product LA419 and its enantiomer LA 455 in a model of affectation of the neurovascular unit; focal myocardial infarction (stroke) and Alzheimer’s disease (PS1A246E-APPSWE)\n\nDuration: January 2011 – December 2012\n\nCommercialization of specific antibodies for neuroscience and other fields of biomedical research produced by the INSTITUTO CAJAL-CSIC\n\nDuration: 2014 – present\n\nFunding\n\nMinistry of Science and Innovation. Government of Spain\n\nHigher Council for Scientific Research (CSIC)\n\nAlice Koplowitz Foundation\n\nLacer Laboratories\n\nNetwork Biomedical Research Center. Bioengineering, Biomaterials and Nanomedicine\n\nCarlos III Health Institute\n\nFCT – Foundation for Science and Technology\n\nMinistry of Education, Universities, Science and Spokesperson. Madrid’s community\n\nActivities\n\nLatest news\n\nWeb accesibility | Legal Warning"
    }
}